Baixar PDF

Outros usuários também visualizaram estes artigos

NOVEL KEY VARIABLES IN THE SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS: A PRACTICAL APPROACH USING MACHINE LEARNING PRC Passos; RDB Dias; SCC Carneiro; IB Nogueira; JMGF Lima; RC Venâncio; ACG Lavor; JVG Gama; RF Pinheiro; SMM Magalhães;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S454
IS FERRITIN A GOOD PREDICTOR OF SURVIVAL ACROSS ALL RISK LEVELS IN MYELODYSPLASTIC NEOPLASMS? INSIGHTS FROM A STRATIFIED COHORT STUDY PRC Passos; RDB Dias; SCC Carneiro; IB Nogueira; RC Venâncio; JVG Gama; JMGF Lima; ACG Lavor; RF Pinheiro; SMM Magalhães;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S446
TRENDS IN MYELODYSPLASTIC SYNDROMES-RELATED MORTALITY IN BRAZIL FROM 2014 TO 2023 PHV Moura; DV Menescal; RDB Dias; SCC Carneiro; IB Nogueira; PRC Passos; JVC Goes; JMGF Lima; RF Pinheiro; SMM Magalhães;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S460-1